Access Restricted: Confidential Investor Materials
"Breastfeeding is the only vital sign managed by intuition alone."
The world's first longitudinal dataset connecting maternal physiology to infant development.
5K-10K paying mothers prove product-market fit, then scale to $15.4B clinical enterprise.
Ship BMMPP, prove traction, lock clinical pilots. 15-80x projected ROI.
What investors ask most often—answered clearly, without hand-waving.
The Problem: 40% of mothers quit breastfeeding within 3 months due to "insufficient supply" anxiety—they have no objective data about milk intake.
Our Approach: Launch as consumer wellness product first (BMMPP). Fast market entry, no FDA delays. Prove product-market fit with paying mothers, then scale to hospitals and regulatory approval.
Why Now: Parents demand quantified solutions. Technology is ready (sensor commoditization, AI maturity). Consumer-first path de-risks the business before expensive hospital/FDA investment.
Total Addressable Market: $15.42B across consumer, hospital, government, and international segments.
Realistic Capture: $150M-$200M ARR by Year 5 (2.3-3.0% penetration).
Path to Valuation: Clear path to $1.0B-$1.2B valuation (Series B+), with $8B-$15B exit potential at scale.
The Only Integrated Ecosystem: MonBe serves consumers, professionals, hospitals, and payers simultaneously. Competitors pick one and stay small.
Network Effects Moat: Consumer data → Professional insights → Hospital adoption creates a virtuous cycle competitors can't replicate.
Technical Edge: 6-sensor fusion (Ultrasound, Bioimpedance, Acoustic, Vibration, Pressure, Temperature) vs. competitors' single sensor. 30-40% higher accuracy. NFC transfer, provisional patent filed Aug 2025.
Founder: Eitan Halfon, Ex-SolarEdge (NASDAQ: SEDG). BSc EE, MSc Economics. Hardware systems at scale.
Go-to-Market:
Dual Revenue Streams: Consumer (B2C) + Professional (B2B)
Consumer: $249 core + $45-65/mo patches + $5-15/mo app premium = $450-700 LTV
Professional: $25K-250K/year hospital software fees (workflow integration, RPM billing, dashboard)
Year 5: $150M-$200M ARR | LTV:CAC >8:1 | 70%+ Gross Margins
WHO and UNICEF have set aggressive 2030 targets for exclusive breastfeeding. Today, the primary driver for failure isn't lack of will—it's anxiety driven by the absence of data.
"Is my baby eating enough?" — has no reliable answer outside a clinic.
Hardware is the entry ticket. Intelligence is the moat. MonBe uses AI-powered 6-sensor fusion to capture the full physiological spectrum of a feeding session.
Soft adhesive breast patch with reusable electronic core. Zero continuous Bluetooth near baby (NFC-sync). Multi-week charge.
Ultrasound, Bioimpedance, Acoustic, Vibration, Pressure, Temperature. 30-40% higher accuracy than single-sensor competitors.
Real-time analysis of flow rate, letdown timing, sucking vigor, and emptying efficiency. Data that builds clinical trust.
Pre-seed strategy: ship the smallest product that mothers pay for and that generates repeatable data. We win by proving demand, retention, and signal quality—fast.
The Milk Graph™
MonBe isn't a gadget; it's an Intelligence Platform. By solving the user interface, we unlock the first objective dataset in lactation history.
MHz piezo for internal duct activity
4-electrode tissue and fullness change
Dual MEMS for suck, swallow, breathe
Jaw motion and sucking rhythm
Suction strength, seal, pattern
Precise skin or milk thermal trend
Full day data in <5s, no always-on radio
Turns signals into intake estimate, latch score, patterns
Timing, intensity, rhythm, feeding phases across every session
Nutritive vs comfort patterns, swallowing signatures, active vs passive time
Preventing $9,500 jaundice readmissions through early-warning intake metrics
6-sensor fusion outperforms single-sensor competitors across all key dimensions.
* Multi-sensor approach provides 30-40% higher accuracy than single-sensor competitors
Defensible revenue across validated market segments.
Direct-to-consumer revenue from day one. Core device + recurring patches + optional premium app.
Pilot programs with lactation teams and hospitals to prove outcomes and build clinical dataset.
Hospital software fees + RPM billing. Hundreds of dollars per dyad depending on workflow and payer mix.
BMMPP shipped, stable UX, repeatable signal capture
5K-10K paying mothers, retention signal, improving models
3-5 pilot sites, validation endpoints, LOIs for Series A
Dataset growth, improved models, IP expansion
5K-10K paying mothers, MVP launch, initial clinical data collection
FDA 510(k) clearance, 3-5 hospital pilots, Series A fundraising
50-100 hospitals, CE Mark, Nordic expansion, $150M-$200M ARR
10% market penetration, $1.5B revenue, strategic exit or IPO
"Join us in building the objective foundation for infant health."
SAFE or Convertible Note for rapid go-to-market velocity.
"I am building what I wish we had for our twins. Engineering rigor, financial discipline, and lived pain."